---
title: "Group 29 Presentation"
format: 
  revealjs:
    embed-resources: true
editor: visual
editor_options: 
  chunk_output_type: console
---

## Introduction

## Materials and Methods

## Analysis 1

## Analysis 2

::::: columns
::: {.column width="50%"}
![](images/analysis2_presentation.jpg)
:::

::: {.column width="50%"}
-   Wide variations in CD marker distribution.
-   **Tissue-related** clusters are common
-   Some markers are universally expressed (e.g. CD45), while others are **lineage-specific**.
:::
:::::

## Analysis 3

::::: columns
::: {.column width="50%"}
:::

::: {.column width="50%"}
:::
:::::

## Analysis 4

:::::::: columns
:::::: {.column width="70%"}
::::: columns
::: {.column width="35%"}
![](../results/08_key_plot_1.png){width="291"} ![](../results/08_key_plot_2.png){width="291"}
:::

::: {.column width="35%" style="font-size: 50%"}
![](../results/08_key_plot_3.png){width="291"}

| Lineage     | Significant CDs |
|-------------|-----------------|
| B cells     | 104             |
| Thymocytes  | 74              |
| CD4 T cells | 51              |
| CD8 T cells | 46              |

: Number of significant CD markers (p \< 0.05)
:::
:::::
::::::

::: {.column width="30%" style="font-size: 30%"}
-   **Table:** B cells had the most significant markers, showing stronger activation changes.
-   **B cells:** Tonsil B cells are more activated (CD69, CD80), while blood B cells mature gradually (CD11a, CD80).
-   **CD4 T cells:** Mature from thymus to blood, losing CD10 and gaining CD25 and CD4_MEM-241.
-   **CD8 T cells:** Move from active thymus cells to mature blood cells with higher CD27 and CD95.
:::
::::::::

## Analysis 5

::::: columns
::: {.column width="50%" style="font-size:70%"}
-   CD4 and CD8 T cells go through parallel stages
-   How

| Pair  | Count |
|-------|-------|
| SP1ap | 24    |
| SP1am | 15    |
| Naive | 18    |
| CM    | 23    |
| EM    | 25    |
| TEMRA | 22    |

: Count of significant CDs
:::

::: {.column width="50%"}
![](images/09_analysis_5_plot.png)
:::
:::::

## Discussion
